In light of the findings by Romera and colleagues that PPARγ agonists increase astrocytic EAAT2 and subsequently reduce extracellular glutamate, which we show that PPARγ-mediated EAAT2 modulation is also applicable to glioma cells. This evidence concerns the gene PPARG and glioma.